Pidilizumab Uses, Dosage, Side Effects and more
Pidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma).
| Trade Name | Pidilizumab |
| Generic | Pidilizumab |
| Pidilizumab Other Names | Pidilizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
